Cat.#: ACPP-1335
| Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1138 | Recombinant Human Semaphorin 7a Protein (6×His Tag) (AC1138) | 50 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1506 | Human NDE1 Protein (AC1506) | 5 µg | inquiry |
| ACPP-1809 | Human Vaspin Protein (AC1809) | 5 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1616 | Human DGCR6 Protein (AC1616) | 5 µg | inquiry |
| ACPP-1789 | Human PEDF Protein (AC1789) | 5 µg | inquiry |
| ACPP-1500 | Mouse PEBP1 Protein (AC1500) | 5 µg | inquiry |
| ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.